Updated
GH ResearchGHRS · Healthcare
$18.61+0.92%
Market cap$1.2B
IndustryBiotechnology
GH Research (GHRS) Superinvestor holders
5 of the superinvestors we track hold GH Research (GHRS) in their latest 13F filings, $4M in total.
Summary
The largest holder is Steve Cohen (Point72 Asset Management), with $1M, 0.0% of the portfolio.
In their latest quarter: 2 opened a new position, 1 added, 1 trimmed.
Who holds it
Each investor's latest 13F filing, largest stake first. What a 13F shows.
| Investor | Last change | Shares | Value | % of portfolio | Filed for |
|---|---|---|---|---|---|
| Steve Cohen Point72 Asset Management |
New position | 50,882 | $1M | 0.0% | Q2 2026 |
| Paul Marshall Marshall Wace |
Trimmed | 46,697 | $1M | 0.0% | Q2 2026 |
| Paul Tudor Jones Tudor Investment Corp |
Added | 34,278 | $921,393 | 0.0% | Q2 2026 |
| David Shaw D. E. Shaw & Co. |
New position | 25,345 | $681,274 | 0.0% | Q2 2026 |
| Didric Cederholm Lion Point Capital |
Held | 10,200 | $274,176 | 1.3% | Q2 2026 |
Holders by quarter
| Quarter | Superinvestors holding it |
|---|---|
| Q2 2026 | 5 |
| Q1 2026 | 4 |
| Q4 2025 | 2 |
| Q3 2025 | 3 |
| Q4 2024 | 2 |
| Q3 2024 | 1 |
| Q2 2024 | 1 |
| Q1 2024 | 1 |
Questions about GH Research
Which superinvestors own GH Research?
5 of the superinvestors we track hold GH Research (GHRS) in their latest 13F filings, $4M in total. Steve Cohen, Paul Marshall, Paul Tudor Jones, David Shaw, Didric Cederholm.
Who is the largest superinvestor holder of GHRS?
The largest holder is Steve Cohen (Point72 Asset Management), with $1M, 0.0% of the portfolio.
From GH Research's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.